130 related articles for article (PubMed ID: 37398413)
21. Targeted therapy in NPM1-mutated AML: Knowns and unknowns.
Wang R; Xu P; Chang LL; Zhang SZ; Zhu HH
Front Oncol; 2022; 12():972606. PubMed ID: 36237321
[TBL] [Abstract][Full Text] [Related]
22. Mutant NPM1-regulated lncRNA HOTAIRM1 promotes leukemia cell autophagy and proliferation by targeting EGR1 and ULK3.
Jing Y; Jiang X; Lei L; Peng M; Ren J; Xiao Q; Tao Y; Tao Y; Huang J; Wang L; Tang Y; Yang Z; Yang Z; Zhang L
J Exp Clin Cancer Res; 2021 Oct; 40(1):312. PubMed ID: 34615546
[TBL] [Abstract][Full Text] [Related]
23. Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation.
Yi S; Wen L; He J; Wang Y; Zhao F; Zhao J; Zhao Z; Cui G; Chen Y
Ann Hematol; 2015 Feb; 94(2):201-10. PubMed ID: 25242579
[TBL] [Abstract][Full Text] [Related]
24. Small molecules enhancers of amyloid aggregation of C-terminal domain of Nucleophosmin 1 in acute myeloid leukemia.
Florio D; Roviello V; La Manna S; Napolitano F; Maria Malfitano A; Marasco D
Bioorg Chem; 2022 Oct; 127():106001. PubMed ID: 35803020
[TBL] [Abstract][Full Text] [Related]
25. Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy.
Wu HC; Rérolle D; Berthier C; Hleihel R; Sakamoto T; Quentin S; Benhenda S; Morganti C; Wu C; Conte L; Rimsky S; Sebert M; Clappier E; Souquere S; Gachet S; Soulier J; Durand S; Trowbridge JJ; Bénit P; Rustin P; El Hajj H; Raffoux E; Ades L; Itzykson R; Dombret H; Fenaux P; Espeli O; Kroemer G; Brunetti L; Mak TW; Lallemand-Breitenbach V; Bazarbachi A; Falini B; Ito K; Martelli MP; de Thé H
Cancer Discov; 2021 Dec; 11(12):3198-3213. PubMed ID: 34301789
[TBL] [Abstract][Full Text] [Related]
26. Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML.
Martelli MP; Rossi R; Venanzi A; Meggendorfer M; Perriello VM; Martino G; Spinelli O; Ciurnelli R; Varasano E; Brunetti L; Ascani S; Quadalti C; Cardinali V; Mezzasoma F; Gionfriddo I; Milano F; Pacini R; Tabarrini A; Bigerna B; Albano F; Specchia G; Vetro C; Di Raimondo F; Annibali O; Avvisati G; Rambaldi A; Falzetti F; Tiacci E; Sportoletti P; Haferlach T; Haferlach C; Falini B
Blood; 2021 Dec; 138(25):2696-2701. PubMed ID: 34343258
[TBL] [Abstract][Full Text] [Related]
27. When the good go bad: Mutant NPM1 in acute myeloid leukemia.
Kunchala P; Kuravi S; Jensen R; McGuirk J; Balusu R
Blood Rev; 2018 May; 32(3):167-183. PubMed ID: 29157973
[TBL] [Abstract][Full Text] [Related]
28. An atypical GABARAP binding module drives the pro-autophagic potential of the AML-associated NPM1c variant.
Mende H; Khatri A; Lange C; Poveda-Cuevas SA; Tascher G; Covarrubias-Pinto A; Löhr F; Koschade SE; Dikic I; Münch C; Bremm A; Brunetti L; Brandts CH; Uckelmann H; Dötsch V; Rogov VV; Bhaskara RM; Müller S
Cell Rep; 2023 Dec; 42(12):113484. PubMed ID: 37999976
[TBL] [Abstract][Full Text] [Related]
29. Type F mutation of nucleophosmin 1 Acute Myeloid Leukemia: A tale of disorder and aggregation.
La Manna S; Florio D; Di Natale C; Scognamiglio PL; Sibillano T; Netti PA; Giannini C; Marasco D
Int J Biol Macromol; 2021 Oct; 188():207-214. PubMed ID: 34364939
[TBL] [Abstract][Full Text] [Related]
30. INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.
Jin H; Yang L; Wang L; Yang Z; Zhan Q; Tao Y; Zou Q; Tang Y; Xian J; Zhang S; Jing Y; Zhang L
J Exp Clin Cancer Res; 2018 Jan; 37(1):8. PubMed ID: 29343273
[TBL] [Abstract][Full Text] [Related]
31. The acute myeloid leukemia-associated Nucleophosmin 1 gene mutations dictate amyloidogenicity of the C-terminal domain.
La Manna S; Scognamiglio PL; Roviello V; Borbone F; Florio D; Di Natale C; Bigi A; Cecchi C; Cascella R; Giannini C; Sibillano T; Novellino E; Marasco D
FEBS J; 2019 Jun; 286(12):2311-2328. PubMed ID: 30921500
[TBL] [Abstract][Full Text] [Related]
32. Induction and Therapeutic Targeting of Human NPM1c
Kaur M; Drake AC; Hu G; Rudnick S; Chen Q; Phennicie R; Attar R; Nemeth J; Gaudet F; Chen J
J Immunol; 2019 Mar; 202(6):1885-1894. PubMed ID: 30710044
[TBL] [Abstract][Full Text] [Related]
33. Direct pro-apoptotic role for NPM1 as a regulator of PIDDosome formation.
Sidi S; Bouchier-Hayes L
Mol Cell Oncol; 2017; 4(5):e1348325. PubMed ID: 29057309
[TBL] [Abstract][Full Text] [Related]
34. Structural insights into amyloid structures of the C-terminal region of nucleophosmin 1 in type A mutation of acute myeloid leukemia.
Di Natale C; La Manna S; Malfitano AM; Di Somma S; Florio D; Scognamiglio PL; Novellino E; Netti PA; Marasco D
Biochim Biophys Acta Proteins Proteom; 2019 Jun; 1867(6):637-644. PubMed ID: 30710643
[TBL] [Abstract][Full Text] [Related]
35. Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice.
Vassiliou GS; Cooper JL; Rad R; Li J; Rice S; Uren A; Rad L; Ellis P; Andrews R; Banerjee R; Grove C; Wang W; Liu P; Wright P; Arends M; Bradley A
Nat Genet; 2011 May; 43(5):470-5. PubMed ID: 21441929
[TBL] [Abstract][Full Text] [Related]
36. Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironment.
Patel SS; Lipschitz M; Pinkus GS; Weirather JL; Pozdnyakova O; Mason EF; Inghirami G; Hasserjian RP; Rodig SJ; Weinberg OK
Mod Pathol; 2020 Jul; 33(7):1380-1388. PubMed ID: 32051557
[TBL] [Abstract][Full Text] [Related]
37. A Curious Novel Combination of
Venanzi A; Rossi R; Martino G; Annibali O; Avvisati G; Mameli MG; Sportoletti P; Tiacci E; Falini B; Martelli MP
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573408
[No Abstract] [Full Text] [Related]
38. Synergistic Effects of the RAR
Fleischmann M; Bechwar J; Voigtländer D; Fischer M; Schnetzke U; Hochhaus A; Scholl S
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610989
[TBL] [Abstract][Full Text] [Related]
39. Nucleophosmin Mutants Promote Adhesion, Migration and Invasion of Human Leukemia THP-1 Cells through MMPs Up-regulation via Ras/ERK MAPK Signaling.
Xian J; Shao H; Chen X; Zhang S; Quan J; Zou Q; Jin H; Zhang L
Int J Biol Sci; 2016; 12(2):144-55. PubMed ID: 26884713
[TBL] [Abstract][Full Text] [Related]
40. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
